2,241 results on '"Rush, A. John"'
Search Results
202. Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression
203. Neutrophil β2-adrenergic receptor coupling efficiency to Gs protein in subjects with post-traumatic stress disorder and normal controls
204. Association Between Bipolar Spectrum Features and Treatment Outcomes in Outpatients With Major Depressive Disorder
205. Natural Language Processing-Based Quantication of the Mental State of Psychiatric Patients
206. The Adolescent Resilience Questionnaire: Validation of a Shortened Version in U.S. Youths
207. Using the NIH Research, Condition and Disease Categorization Database for research advocacy: Schizophrenia research at NIMH as an example
208. Pramipexole Augmentation of Buprenorphine Improves Pain and Depression in Opioid Use Disorder
209. Vagus Nerve Stimulation in Patients Receiving Maintenance Therapy With Electroconvulsive Therapy
210. What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI
211. Improving Depression Outcome by Patient-Centered Medical Management
212. Positive and negative valence systems in major depression have distinct clinical features, response to antidepressants, and relationships with immunomarkers
213. Platelet α2-adrenergic receptor coupling efficiency to Gi protein in subjects with post-traumatic stress disorder and normal controls
214. Combining Antidepressant Medications: A Good Idea?
215. Treatment and Prevention of Depression in Women.
216. Age-Related Characteristics of Depression: A Preliminary STAR*D Report
217. Genome-wide association study of suicide attempts in mood disorder patients
218. Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results
219. What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
220. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression
221. Release bias in accessing medical records in clinical trials: a STAR*D report
222. Writing and Publishing Your Research Findings
223. Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder
224. Can Phase III Trial Results of Antidepressant Medications Be Generalized to Clinical Practice? A STAR*D Report
225. Predictors of Attrition During One Year of Depression Treatment: A Roadmap to Personalized Intervention
226. Screening for Major Depression in Private Practice
227. Quality improvement methods as applied to a multicenter effectiveness trial—STAR*D
228. Obsessive compulsive symptoms in schizophrenia: Frequency and clinical features
229. Brief Psychiatric Rating Scale Expanded Version: How do new items affect factor structure?
230. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia
231. Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features
232. Gender differences in depression: Findings from the STAR*D study
233. A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial
234. Assessing insomnia severity in depression: comparison of depression rating scales and sleep diaries
235. A Randomized Trial of Citalopram versus Placebo in Outpatients with Asthma and Major Depressive Disorder: A Proof of Concept Study
236. Vagus Nerve Stimulation for Treatment-Resistant Depression: A Randomized, Controlled Acute Phase Trial
237. Effects of 12 Months of Vagus Nerve Stimulation in Treatment-Resistant Depression: A Naturalistic Study
238. A One-Year Comparison of Vagus Nerve Stimulation with Treatment as Usual for Treatment-Resistant Depression
239. Depression Outcomes of Spanish- and English-Speaking Hispanic Outpatients in STAR*D
240. Children of Depressed Mothers 1 Year After the Initiation of Maternal Treatment: Findings From the STAR*D-Child Study
241. An Open Pilot Study of the Combination of Escitalopram and Bupropion-SR for Outpatients with Major Depressive Disorder
242. Developing the evidence for evidence-based practice
243. Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents
244. Clinically Relevant Findings from STAR*D
245. Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report
246. STAR*D: Have We Learned the Right Lessons?
247. Psychotherapies for Depressive Disorders: A Review
248. A 60-year-old Man with Major Depression
249. Effect of Age at Onset on the Course of Major Depressive Disorder
250. Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.